Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine the influence medical or surgical treatment for patent ductus arteriosus in preterm infants on cerebral and renal tissue oxygenation and on cardiac output.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Ulm
• Treatments: Ibuprofen; Indomethacin

Criteria

Inclusion Criteria:

• Newborn infant below 34 weeks postmenstrual age at the time of birth

• Patent ductus arteriosus with signs of hemodynamic relevance (as judged by the attending neonatologist)

• parental informed consent

Exclusion Criteria:

• Patent ductus arteriosus as part of malformation syndrome

• Additional major cardiovascular malformations